Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wärtsilä selected as a preferred supplier for AGL Energy’s up to 1,000 MW grid-scale energy storage plans

Wärtsilä Corporation, Press release, 14 January 2021 at 11.00 AM EETAGL Energy Limited, one of Australia’s leading integrated energy companies, has selected Wärtsilä as one of the two suppliers for their up to 1,000 MW grid-scale energy storage plans. Wärtsilä has signed a non-exclusive five-year Large Scale Storage System Frame Agreement to supply energy storage projects in partnership with AGL. This agreement will reduce tender timeframes for individual projects, enabling faster project schedules and commercial operation. In addition to its state-of-the-art energy storage and energy

Invitation to webcasted telephone conference – Q4 2020

BillerudKorsnäs’ year-end report for 2020 will be published on Friday 29 January at around 07.00 CET.BillerudKorsnäs’ President and CEO Christoph Michalski and the company’s CFO Ivar Vatne will present the year-end report via a webcasted telephone conference on the same day at 9.00 CET. The presentation will be held in English and will be followed by a Q&A session.The presentation can be followed on https://edge.media-server.com/mmc/p/7tuh95sm. To participate via telephone and thereby be able to ask questions, please use any of the following telephone numbers and pin code 33160538#.

Aker BioMarine launches INVI, a novel protein for human consumption

Aker BioMarine is expanding its ingredient portfolio with the launch of INVI, ahydrolyzed protein isolate with a complete amino acid profile, which is alsorich in minerals, including calcium and magnesium. INVI is ideal forincorporation into powder and ready-to-drink beverages, as well as broader foodand beverage applications for brands looking to grow their product portfoliowith a high quality and sustainable protein source.INVI is a highly concentrated protein isolate with a protein purity above 90%.INVI has a complete amino acid profile, containing all the essential amino

Lindex celebrates women’s differences in this spring’s underwear campaign

Lindex launches this spring's underwear campaign with the message ‘Love your breasts. We do’. With the campaign, Lindex wants to celebrate women’s differences and encourage every woman to love herself and her breasts just as they are. “Women’s breasts have always been subject to various symbolic metaphors – grapefruits, lemons, mountain peaks and much more. We think it’s time to take back and change the way we look at these. With warmth and a sense of humour, we want to show how every woman owns her metaphor and its meaning. We simply want to encourage everyone to be themselves

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 11 - 14 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Wärtsilä’s Financial Statements Bulletin 2020 to be published 28 January 2021 at 8.30 a.m. local time

Wärtsilä Corporation, Press release, 14 January 2021 at 10:00 a.m. EETWärtsilä’s Financial Statements Bulletin 2020 to be published 28 January 2021 at 8.30 a.m. local time Wärtsilä Corporation will publish its Financial Statements Bulletin for the year 2020 on Thursday 28 January 2021 at 8.30 a.m. Finnish time. The report will be available in pdf-format on the company website at www.wartsila.com after publishing.A virtual analyst and press conference will be held as a webinar on the same day, Thursday 28 January 2021, at 10.00 a.m. Finnish time (8.00 a.m. UK time).If you only wish to

The architecture of warehouse construction is becoming more visual

Lehto Group PlcPress release14 January 2021Lehto Group will construct a new self-service storage facility for Pelican Self Storage in Varisto, Vantaa. Nowadays, storage facilities must be located about five minutes away from customers At the same time, the architecture of these facilities is becoming moreimportant due to their integration into the cityscape. Photo: L Arkkitehdit Oy. By the end of next year, Lehto Group will construct a new self-service storage facility unit for Pelican Self Storage in Varisto, Vantaa. In addition to a traditional self-service storage

Invitation to media and analyst briefing for Ericsson Q4 and full year 2020 report

· Report to be released at approximately 7:00 AM CET on January 29, 2021 · One conference call for analysts, investors and journalists at 9:00 AM CETEricsson's (NASDAQ: ERIC) financial report for the fourth quarter and full year of 2020 will be published at approximately 7:00 AM CET on January 29, 2021. The company will issue a press release with the complete financial report attached, including tables, in PDF format. Following publication of the press release, the financial report will be available on Ericsson's website: www.ericsson.com/en/investors/financial-reports/interim-

Invitation to Telia Company’s Investor Brief

Telia Company invites investors, analysts and media to an Investor Brief January 29, 2021.The presentation will start at 11:00 CET and will include a strategy as well as an operational and financial ambition update by President and CEO Allison Kirkby, COO Rainer Deutschmann and CFO Per Christian Mørland. The event ends at around 14:00 CET including a Q&A session. Earlier in the day, at around 07:00 CET, Telia Company will announce its year-end report January-December 2020. The Investor Brief presentation will also cover the year-end results. A link to the live webcast will be available

Basware Corporation share issue to the company itself without consideration

Basware Corporation, stock exchange release January 14, 2021 at 9:45 am EETThe Board of Directors of Basware Corporation has on January 14, 2021, pursuant to the share issue authorization granted to it by the Annual General Meeting held on June 4, 2020, resolved on an issue of 43,000 new shares in the company to the company itself without consideration. The new shares to be issued to the company will be used for reward payments under the company's incentive programs. The new shares to be issued are of the same class as the existing shares in the company. The total number of the company's

The board of directors of InDex Pharmaceuticals Holding AB has resolved on a fully guaranteed rights issue of approximately MSEK 533

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. 14 January 2021 – The board of directors of InDex Pharmaceuticals Holding AB (publ) (”InDex” or the ”Company”) has, with the support of the authorisation from the extraordinary general meeting held on 12 January 2021, resolved on a rights issue of approximately 444 million shares at a subscription price of SEK 1.20

Update on Vewd litigation

We refer to the stock exchange announcement dated November 30, 2020.MFC has not yet made such purchase and it has applied to the Court for an extension for the time to do so to February 19, 2021. MFC has been ordered to pay Otello’s costs of this part of the proceedings (having previously been ordered to pay and having paid the costs of the liability stage). MFC was required to make a payment to Otello in the amount of £1.25 million by December 31, 2020 on account of Otello’s costs but has failed to make such payment. If the total costs are not agreed, they will be assessed and

Dignitana publishes January newsletter

Dignitana AB today publishes the January newsletter featuring strong opportunities for the company with Mammazentrum Hamburg and GenesisCare in Australia as well as details from the recent Directed Share Issue. To read the newsletter click here  or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email,

Healthcare region pioneering digital pathology reviews in Denmark with Sectra—aims to significantly shorten cancer turn-around times

Linköping, Sweden – January 14, 2021 – The healthcare provider Region of Southern Denmark has gone live with a digital pathology solution from international medical imaging IT and cybersecurity company Sectra  (STO: SECT B). The IT solution makes it possible for pathologists at the region’s four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This supports increased efficiency in primary diagnostics, thereby improving cancer care.“Despite disruptions caused by the COVID-19 pandemic, the project has been carried out

Mikko Valorinta appointed Enfo’s CEO

The Board of Enfo Oyj has appointed Mikko Valorinta new CEO of Enfo.Valorinta starts in his position in the beginning of March 2021. He joins Enfo from Capgemini, where he has been Managing Director for Capgemini Finland Oy since 2013. Before that, Valorinta worked as head of different units as well as managing consultant at Capgemini from 2002. He has a Master of Science (industrial engineering) and a Doctor of Science (technology) degree. “I very much look forward to starting as Enfo’s CEO. Enfo has a customer-oriented culture, excellent customer satisfaction and strong Nordic

Cereno Scientific signs CRO for Phase II study with drug candidate CS1 in rare disease PAH

Cereno Scientific today announced that the company has signed a letter of intent with the global contract research organization (CRO) Worldwide Clinical Trials . Worldwide will provide support and guidance in the final preparatory steps as well as conduct the clinical Phase II study with drug candidate CS1 in pulmonary arterial hypertension (PAH). The clinical trial application process for the study has been initiated and the study start is expected to be

Alfa Laval acquires a stake in AMI Global

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has acquired a 20 percent stake in AMI Global, specialized in end-to-end industrial Internet of Things’ (IoT) solutions for rotating equipment, to further strengthen Alfa Laval’s position in connected services, such as condition monitoring. The signing and closing date was December 31, 2020.AMI Global is a portfolio company of Cimbria Capital, which is a private equity firm based in the United States and Scandinavia. The 20 percent stake will enable Alfa Laval to further strengthen its competence in

Atlas Copco’s Q4 report 2020 and invitation to the conference call, January 29

Nacka, Sweden, January 14, 2021: Atlas Copco will publish its Q4 results for 2020 on Friday, January 29, at approximately 12:00 PM CET. A conference call for investors, analysts and media will be held at 2:00 PM CET.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Hans Ola Meyer, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. The conference call will be broadcasted live on the web. Please see our website www.atlascopcogroup.com/investor-relations for the webcast link and presentation

New patent approval in Hong Kong for Episurf Medical

The Intellectual Property Department (IPD) of Hong Kong has announced its intention to grant another patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Method and node for manufacturing a surgical kit for cartilage repair”, covers a medical image segmentation process for 3D visualisation of anatomical joints. Image segmentation is a part of the technology around Episurf Medical’s individualised joint implants and surgical instruments. “This patent covers important details of the imaging process that forms the basis for the company’s Episealer® technology, and we are happy

NeoDynamics will be granted another European patent for its pulse biopsy tools

STOCKHOLM – January 14, 2020. NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, today announces that the European Patent Office (EPO) has issued a Communication under Rule 71(3) EPC (Notice of Allowance) and intends to grant a European patent for NeoDynamics pulse biopsy tools, including a multi-purpose driver supporting several different needle options. The decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by

Obducat receives order for an MC 204 fully automated resist processing tool from a customer in Asia

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received an order from a customer in Asia, for the supply of fully automated MC 204 resist processing tool. The order value amounts to approx. 7.5 million SEK. The MC 204 tool will be installed in the cleanroom facilities of the customer where it will be used for development and pilot production primarily focused on components related to ICT (Information and Communication Technology). Further information cannot be disclosed for the time being due to confidentiality

KONE publishes January 1-December 31, 2020 Financial Statement Bulletin on Thursday, January 28, 2021 at 12:30 p.m. EET and Annual Review 2020 at 12:45 p.m. EET

KONE Corporation, press release, January 14, 2021 at 9.30 a.m. EET Financial Statement Bulletin and Annual Review KONE Corporation will publish its Financial Statement Bulletin for the January 1-December 31, 2020 accounting period on Thursday, January 28, 2021 at 12:30 p.m. EET. The report will be available on www.kone.com after publishing. The Annual Review 2020, which includes the consolidated financial statements, the parent company financial statements, the Board of Director's report and the Corporate Governance Statement, will be published on the same day at 12:45 p.m. EET. A

Nextory is preparing to launch in Norway - agreement signed with Cappelen Damm

Nextory and Norway's largest publisher Cappelen Damm have agreed to enter a distribution agreement. Nextory can now also reveal that a launch in Norway will take place before the summer of 2021. When launching the Norwegian Nextory app, Cappelen Damm's large audiobook catalog will be available to readers and listeners in Norway. Nextory is now available in Sweden, Finland, Denmark, Germany, Austria, Switzerland and The Netherlands. Norway will be the eighth market launch for the book service and in 2021 there are plans to launch in several other European countries. – We are very

Attana features in Pharma Publications with AVA™ as a leading-edge solution for improved SARS-CoV-2 testing and immunity profiling

Recently, an article about Attana’s first non-clinical in vitro diagnostic (IVD) device, Attana Virus Analytics – AVA™, was published in IBI (International Biopharmaceutical Industry). The article explains how AVA could help provide invaluable insights when assessing patient immunity for SARS-CoV-2.A brief summary of the article: The Challenge of Assessing SARS-CoV-2 ImmunityOne of the main challenges with SARS-CoV-2 is assessing patient immunity. Conventional testing methods focuse on the binary presence of virus-specific antibodies (e.g. IgA, IgM and IgG). However, SARS-CoV-2

There are no items matching the current filter
There are no more items matching the current filter
Back to top